Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Radiation therapy uses high-energy rays or small particles to kill cancer cells. This type of treatment is given by a doctor called a radiation oncologist. Radiation therapy may be used in different situations:
Most often, the radiation is focused on the tumor from a source outside the body. This is called external beam radiation therapy (EBRT). This type of radiation therapy is much like getting an x-ray, but the dose of radiation is much higher.
Before your treatments start, the radiation team will determine the correct angles for aiming the radiation beams and the proper dose of radiation. This planning session, called simulation, usually includes getting imaging tests such as CT or MRI scans.
In most cases, the total dose of radiation is divided into daily amounts (usually given Monday through Friday) over several weeks. At each treatment session, you lie on a special table while a machine delivers the radiation from precise angles. The treatment is not painful. Each session lasts about 15 to 30 minutes, and much of that time is spent making sure the radiation is aimed correctly. The actual treatment time each day is much shorter.
High doses of radiation therapy can damage normal brain tissue, so doctors try to deliver the radiation to the tumor while giving the lowest possible dose to normal surrounding brain areas. Several techniques can help doctors focus the radiation more precisely:
Three-dimensional conformal radiation therapy (3D-CRT): 3D-CRT uses the results of imaging tests such as MRI and special computers to map the location of the tumor precisely. Several radiation beams are then shaped and aimed at the tumor from different directions. Each beam alone is fairly weak, which makes it less likely to damage normal tissues, but the beams converge at the tumor to give a higher dose of radiation there.
Intensity modulated radiation therapy (IMRT): IMRT is an advanced form of 3D therapy. It uses a computer-driven machine that moves around the patient as it delivers radiation. Along with shaping the beams and aiming them at the tumor from several angles, the intensity (strength) of the beams can be adjusted to limit the dose reaching the most sensitive normal tissues. This may let the doctor deliver a higher dose to the tumor. Many major hospitals and cancer centers now use IMRT.
Volumetric modulated arc therapy (VMAT): This newer technique is similar to IMRT. For this treatment, the patient lies on a table, which passes through the machine delivering the radiation. The source of the radiation (the linear accelerator) rotates around the table in an arc, delivering the beams from different angles. A computer controls the intensity of the beams to help keep the radiation focused on the tumor. It’s not yet clear if this approach results in better outcomes than IMRT, although it does allow the radiation to be given over less time in each treatment session.
Conformal proton beam radiation therapy: Proton beam therapy uses an approach similar to 3D-CRT. But instead of using x-rays, it focuses proton beams on the tumor. Protons are positive parts of atoms. Unlike x-rays, which release energy both before and after they hit their target, protons cause little damage to tissues they pass through and then release their energy after traveling a certain distance. This lets doctors deliver more radiation to the tumor and do less damage to nearby normal tissues.
This approach may be more helpful for brain tumors that have distinct edges (such as chordomas), but it is not clear if it will be useful for tumors that typically grow into or mix with normal brain tissue (such as astrocytomas or glioblastomas). There are a limited number of proton beam centers in the United States at this time.
Stereotactic radiosurgery (SRS)/stereotactic radiotherapy (SRT): This type of treatment delivers a large, precise radiation dose to the tumor area in a single session (SRS) or in a few sessions (SRT). (There is no actual surgery in this treatment.) It may be used for some tumors in parts of the brain or spinal cord that can’t be treated with surgery or when a patient isn’t healthy enough for surgery.
A head frame might be attached to the skull to help aim the radiation beams. (Sometimes a face mask is used to hold the head in place instead.) Once the exact location of the tumor is known from CT or MRI scans, radiation is focused at the tumor from many different angles. This can be done in 2 ways:
SRS typically delivers the whole radiation dose in a single session, though it may be repeated if needed. For SRT (sometimes called fractionated radiosurgery), doctors give the radiation in several treatments to deliver the same or a slightly higher dose. Frameless techniques are now available to make this more comfortable.
Image-guided radiation therapy (IGRT): For IGRT, an imaging test such as a CT scan is done just before each treatment to help better guide the radiation to its target. IGRT is typically used along with some of the more precise techniques for delivering radiation described above. It is most useful when the radiation needs to be delivered very precisely, such as when a tumor is very close to vital structures.
Whole brain and spinal cord radiation therapy (craniospinal radiation): If tests like an MRI scan or lumbar puncture find the tumor has spread along the covering of the spinal cord (meninges) or into the surrounding cerebrospinal fluid, radiation may be given to the whole brain and spinal cord. Some tumors such as ependymomas and medulloblastomas are more likely to spread this way and often require craniospinal radiation.
In brachytherapy, radioactive material is inserted directly into or near the tumor. This can be done during surgery to remove the brain tumor, or it might be an option if the tumor comes back after treatment.
An example of this treatment approach is known as GammaTile. These are small tiles made mainly of collagen, which have small radioactive ‘seeds’ in them. They are placed in the lining of the open space that is created when a brain tumor is removed. The radiation they give off travels only a short distance, so it’s not likely to affect other parts of the brain. Over time, the tiles themselves are absorbed by the body, while the seeds lose their radioactivity and can be left in place.
A possible advantage of this approach is that it allows radiation to be given to the area right after surgery, as opposed to having to wait several weeks, which is often the case with external radiation. However, this approach also has some limits, such as not being able to reach tumor cells that are farther away from the original tumor.
Radiation is more harmful to tumor cells than it is to normal cells. Still, radiation can also damage normal brain tissue, which can lead to side effects.
Side effects during or soon after treatment: Some people become irritable and tired during the course of radiation therapy. Nausea, vomiting, and headaches are also possible side effects but are uncommon. Sometimes dexamethasone (a corticosteroid) or other drugs can help relieve these symptoms. Some people might have hair loss in areas of the scalp that get radiation. Other side effects are also possible, depending on where the radiation is aimed.
Problems with thinking and memory: A person may lose some brain function if large areas of the brain get radiation. Problems can include memory loss, personality changes, and trouble concentrating. There may also be other symptoms depending on the area of brain treated and how much radiation was given. These risks must be balanced against the risks of not using radiation and having less control of the tumor.
Radiation necrosis: Rarely after radiation therapy, a mass of dead (necrotic) tissue forms at the site of the tumor in the months or years after radiation treatment. This can often be controlled with corticosteroid drugs, but surgery may be needed to remove the necrotic tissue in some instances.
Increased risk of another tumor: Radiation can damage genes in normal cells. As a result, there is a small risk of developing a second cancer in an area that got radiation — for example, a meningioma of the coverings of the brain, another brain tumor, or less likely a bone cancer in the skull. If this develops, it's usually many years after the radiation is given. This small risk should not prevent those who need radiation from getting treatment.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Dorsey JF, Salinas RD, Dang M, et al. Chapter 63: Cancer of the central nervous system. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
National Cancer Institute Physician Data Query (PDQ). Adult Central Nervous System Tumors Treatment. 2020. Accessed at www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq on February 14, 2020.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. V.3.2019. Accessed at www.nccn.org/professionals/physician_gls/pdf/cns.pdf on February 14, 2020.
Scaringi C, Agolli L, Minniti G. Technical advances in radiation therapy for brain tumors. Anticancer Res. 2018;38(11):6041-6045.
Last Revised: May 16, 2023
Donate now so we can continue to provide access to critical cancer information, resources, and support to improve lives of people with cancer and their families.